161 related articles for article (PubMed ID: 36534235)
21. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls.
Sergentanis TN; Economopoulos KP
Mol Biol Rep; 2011 Nov; 38(8):4955-63. PubMed ID: 21161398
[TBL] [Abstract][Full Text] [Related]
22. Significance of cyclin D1 polymorphisms in patients with head and neck cancer.
Sabir M; Baig RM; Mahjabeen I; Kayani MA
Int J Biol Markers; 2013 Apr; 28(1):49-55. PubMed ID: 23125009
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer and cyclin D1 gene polymorphism in Turkish women.
Yaylim-Eraltan I; Ergen A; Görmüs U; Arikan S; Küçücük S; Sahin O; Yigit N; Yildiz Y; Isbir T
In Vivo; 2009; 23(5):767-72. PubMed ID: 19779113
[TBL] [Abstract][Full Text] [Related]
24. CCND1 rs9344 polymorphisms are associated with the genetic susceptibility to cervical cancer in Chinese population.
Wang N; Qian X; Wang S; Gao H; Wang L; Huo Y; Zhang S
Mol Carcinog; 2012 Feb; 51(2):196-205. PubMed ID: 21594903
[TBL] [Abstract][Full Text] [Related]
25. Contribution of personalized Cyclin D1 genotype to triple negative breast cancer risk.
Liu LC; Su CH; Wang HC; Chang WS; Tsai CW; Maa MC; Tsai CH; Tsai FJ; Bau DT
Biomedicine (Taipei); 2014; 4(1):3. PubMed ID: 25520916
[TBL] [Abstract][Full Text] [Related]
26. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis.
Liao D; Wu Y; Pu X; Chen H; Luo S; Li B; Ding C; Huang GL; He Z
PLoS One; 2014; 9(11):e113299. PubMed ID: 25409185
[TBL] [Abstract][Full Text] [Related]
27. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
[TBL] [Abstract][Full Text] [Related]
28. The significant association of CCND1 genotypes with colorectal cancer in Taiwan.
Huang CY; Tsai CW; Hsu CM; Chang WS; Shui HA; Bau DT
Tumour Biol; 2015 Aug; 36(8):6533-40. PubMed ID: 25809706
[TBL] [Abstract][Full Text] [Related]
29. Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers.
Grieu F; Malaney S; Ward R; Joseph D; Iacopetta B
Anticancer Res; 2003; 23(5b):4257-9. PubMed ID: 14666635
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases.
Naidu R; Yip CH; Taib NA
Neoplasma; 2008; 55(2):87-95. PubMed ID: 18237245
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of cyclin D1 polymorphisms on prostate-specific antigen recurrence after radical prostatectomy.
Yu CC; Lin VC; Huang CY; Liu CC; Wang JS; Wu TT; Pu YS; Huang CH; Huang CN; Huang SP; Bao BY
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S492-9. PubMed ID: 23354566
[TBL] [Abstract][Full Text] [Related]
32. Association of cyclin D1 genotype with breast cancer risk and survival.
Shu XO; Moore DB; Cai Q; Cheng J; Wen W; Pierce L; Cai H; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):91-7. PubMed ID: 15668481
[TBL] [Abstract][Full Text] [Related]
33. Significant association of cyclin D1 single nucleotide polymorphisms with oral cancer in taiwan.
Tsai MH; Tsai CW; Tsou YA; Hua CH; Hsu CF; Bau DT
Anticancer Res; 2011 Jan; 31(1):227-31. PubMed ID: 21273603
[TBL] [Abstract][Full Text] [Related]
34. CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis.
Ni J; Wang M; Wang M; Fu S; Zhou D; Zhang Z; Han S
J Cancer Res Clin Oncol; 2011 Mar; 137(3):489-94. PubMed ID: 20473525
[TBL] [Abstract][Full Text] [Related]
35. Functional role of CyclinD1 polymorphism (G870A) in modifying susceptibility and overall survival of North Indian lung cancer patients.
Pandey A; Bahl C; Sharma S; Singh N; Behera D
Tumori; 2018 Jun; 104(3):179-187. PubMed ID: 30086699
[TBL] [Abstract][Full Text] [Related]
36. Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibility: a case-control study.
Govatati S; Singamsetty GK; Nallabelli N; Malempati S; Rao PS; Madamchetty VK; Govatati S; Kanapuram R; Narayana N; Bhanoori M; Kassetty K; Nallanchakravarthula V
Tumour Biol; 2014 Dec; 35(12):12059-67. PubMed ID: 25146682
[TBL] [Abstract][Full Text] [Related]
37. Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley: a high risk area.
Hussain S; M Y; Thakur N; Salam I; Singh N; Mir MM; Bhat MA; Siddiqi MA; Das BC; Bharadwaj M
Mol Carcinog; 2011 Jul; 50(7):487-98. PubMed ID: 21268129
[TBL] [Abstract][Full Text] [Related]
38. ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patients.
Madrid-Paredes A; Cañadas-Garre M; Sánchez-Pozo A; Segura-Pérez AM; Chamorro-Santos C; Vergara-Alcaide E; Castillo-Portellano L; Calleja-Hernández MÁ
Pharmacol Res; 2016 Jun; 108():111-118. PubMed ID: 27137881
[TBL] [Abstract][Full Text] [Related]
39. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
40. Relationship between cyclin D1 (A870G) gene polymorphism and lung cancer.
Cakina S; Gulyasar T; Ozen A; Sipahi T; Kocak Z; Sener S
Indian J Biochem Biophys; 2013 Jun; 50(3):233-6. PubMed ID: 23898488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
